Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
JNJ-7777120
Cat. No.:
OB0225LY-0132
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
JNJ-7777120 is a selective non-imidazole histamine H4 receptor antagonist.
Synonym:
JNJ7777120; 459168-41-3; 1-[(5-Chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine; (5-Chloro-1H-indol-2-yl)(4-methylpiperazin-1-yl)methanone; 1-((5-Chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine; 5-Chloro-2-[(4-methylpiperazin-1-yl)carbonyl]-H-indole; (5-Chloro-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-metha none
CAS No.:
459168-41-3
Compound CID:
4908365
Formula:
C14H16ClN3O
Formula Weight:
277.75
Specification
Relative Density:
1.322 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
JNJ-7777120 can be used for neurodegenerative disease research.
Library Information
Targets:
Histamine receptor
Receptors:
H4 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
f5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
40 mg/mL; 144.01 mM
Special Max Solubility:
1eq. HCl: 27.8 mg/mL
